Stay updated on RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Sign up to get notified when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.

Latest updates to the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page
- Check3 days agoChange DetectedARISE-3 results have been posted and the study record now includes updated inclusion/exclusion criteria. In addition, several outcomes and related data fields have been added or revised, aligning the record with the latest study documentation.SummaryDifference6%

- Check10 days agoChange DetectedIn the Study Record Dates section, several QC-related timestamp entries were removed, including 2021-11-03 and the November 2021 entries for Certification/Extension First Posted and Certification/Extension First Submitted that Met QC Criteria.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new published version of the study page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new revision of the study details. The previous revision tag v3.6.3 was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a minor maintenance update to the page. The core study information remains unchanged.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the page revision history.SummaryDifference0.1%

Stay in the know with updates to RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.